The series B financing was led by Bay City Capital and included Integral Capital Partners as well as current investors Delphi Ventures and Onset Ventures.
Peter Edelstein, president and CEO of Aragon Surgical, said: “Along with our current top-tier investors, our new investors bring tremendous experience at a critical time in our company’s history, with the recent launch of our first product and with several additional products in development.”